Study of the Blood Concentrations of Two Formulations of REGN2222 in Healthy Subjects
Clinical trial NCT02828397 · COMPLETED
Trial details
- NCT number
- NCT02828397
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2016-09-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.